A population-based study in Japan has revealed a gradual increase in the rates of therapy-related acute myeloid leukemia (tAML) in recent years, especially after breast cancer treatment, a study showed on Monday. 

The findings, published by Wiley online in Cancer, a peer-reviewed journal of the American Cancer Society, showed that some therapies used to treat cancer may increase the risk of later developing cancers that affect the blood.